1:10 Integrating Real-World Evidence into Health Technology Assessments to Address Data Gaps & Drive Market Access Success
Time: 1:15 pm
day: Day 1 PM pt2
Details:
- Standardize RWE data collection and reporting methods to reduce inconsistencies and improve the credibility of submissions to HTA bodies
- Use RWE to supplement clinical trial data, providing a more comprehensive view of a treatment’s real-world effectiveness, safety, and cost-effectiveness
- Foster collaboration between clinical, regulatory, and market access teams to ensure RWE aligns with HTA criteria and accelerates market access decisions
